CBD risks and the chance to rein in supplements

A marijuana derivative called cannabidiol, or CBD, has begun making its way into supplements and even into foods, a use that runs afoul of an FDA designation of the compound as a prescription drug. A Harvard Medical School associate professor says CBD’s tangled legal status may provide an opportunity not only to clear up its status, but to bring clarity to the entire supplements industry.

Alvin Powell • harvard
Aug. 2, 2019 ~12 min

Tags:  harvard-medical-school  health-medicine  alvin-powell  cannabis  cambridge-health-alliance  cannabidiol  cbd  food-and-drug-administration  pieter-cohen  supplements

Page 1 of 1